Patients should feel empowered to ask questions, express concerns, and participate actively in shared decision-making regarding their weight management treatment plan
Gentle, well-tolerated options may be better for GLP-1 users who already have stomach discomfort
Novo Nordisk to offer Wegovy weight loss drug in PH this year MANILA, Philippines Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year Wegovy, its approved weight loss treatment for individuals with obesity
The activity-related end points physical activity level and activity-induced EE decreased with liraglutide 3.0 mg compared with placebo, but only the difference in mean activity-induced EE was statistically significant ( P =0.03)
SBP reduction was mostly mediated by weight loss (7794%) in SURPASS-1, -2 and -3, while mechanisms independent from weight loss accounted for most of the tirzepatide benefit on SBP in SURPASS-4 and -5 (57 and 73%, respectively) [77]